T cell immunity prevents recurrent severe COVID-19
What is a T cell?
- T cell, also called T lymphocyte, is a type of leukocyte (white blood cell) that is an essential part of the immune system.
- T cells are one of two primary types of lymphocytes—B cells being the second type—that determine the specificity of immune response to antigens (foreign substances) in the body.
Origin and differentiation
- T cells originate in the bone marrow and mature in the thymus.
- In the thymus, T cells multiply and differentiate into helper, regulatory, or cytotoxic T cells or become memory T cells.
- They are then sent to peripheral tissues or circulate in the blood or lymphatic system.
Functions of T cells
- Once stimulated by the appropriate antigen, helper T cells secrete chemical messengers called cytokines, which stimulate the differentiation of B cells into plasma cells (antibody-producing cells).
- Regulatory T cells act to control immune reactions, hence their name.
- Cytotoxic T cells, which are activated by various cytokines, bind to and kill infected cells and cancer cells.
- Because the body contains millions of T and B cells, many of which carry unique receptors, it can respond to virtually any antigen.
Why in News?
- Natural exposure or infection with the novel coronavirus may “prevent recurrent episodes of severe COVID-19”, says a paper published in Cell by a Swedish institute.
- This is because, once infected with SARS-CoV-2, the immune system elicits “robust, broad and highly functional memory T cell responses”.
More in the News
The study found SARS-CoV-2-specific T cells even in family members who have been exposed to the virus but have tested negative on antibody blood tests.
SARS-CoV-2-specific T cells were also seen in convalescent (recovered) individuals with a history of asymptomatic infection and mild COVID-19 disease.
Significance of the study
The researchers were able to detect similar memory T cell responses directed against the internal and surface proteins (membrane and/or spike) of the virus in some people in whom SARS-CoV-2-specific antibodies could not be detected.
Studies about development of natural immunity against Covid-19 have largely been limited to prevalence of antibodies.
Reference:
- https://www.thehindu.com/sci-tech/science/sars-cov-2-specific-t-cell-immunity-prevents-recurrent-severe-covid-19-disease/article32363678.ece
Subscribe
Login
0 Comments